These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1715320)

  • 1. Antigenic cross-reactivity and functional inhibition by antibodies to Clostridium difficile toxin A, Streptococcus mutans glucan-binding protein, and a synthetic peptide.
    Wren BW; Russell RR; Tabaqchali S
    Infect Immun; 1991 Sep; 59(9):3151-5. PubMed ID: 1715320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological characteristics of a synthetic peptide associated with a catalytic domain of mutans streptococcal glucosyltransferase.
    Smith DJ; Taubman MA; King WF; Eida S; Powell JR; Eastcott J
    Infect Immun; 1994 Dec; 62(12):5470-6. PubMed ID: 7960128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A.
    Frey SM; Wilkins TD
    Infect Immun; 1992 Jun; 60(6):2488-92. PubMed ID: 1375199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenicity and immunogenicity of a synthetic peptide derived from a glucan-binding domain of mutans streptococcal glucosyltransferase.
    Smith DJ; Taubman MA; Holmberg CF; Eastcott J; King WF; Ali-Salaam P
    Infect Immun; 1993 Jul; 61(7):2899-905. PubMed ID: 8514393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy induced by recombinant Clostridium difficile toxin fragments.
    Leuzzi R; Spencer J; Buckley A; Brettoni C; Martinelli M; Tulli L; Marchi S; Luzzi E; Irvine J; Candlish D; Veggi D; Pansegrau W; Fiaschi L; Savino S; Swennen E; Cakici O; Oviedo-Orta E; Giraldi M; Baudner B; D'Urzo N; Maione D; Soriani M; Rappuoli R; Pizza M; Douce GR; Scarselli M
    Infect Immun; 2013 Aug; 81(8):2851-60. PubMed ID: 23716610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: studies of pneumococcal type 14, Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice.
    Pavliakova D; Moncrief JS; Lyerly DM; Schiffman G; Bryla DA; Robbins JB; Schneerson R
    Infect Immun; 2000 Apr; 68(4):2161-6. PubMed ID: 10722615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficile.
    Ward SJ; Douce G; Dougan G; Wren BW
    Infect Immun; 1999 Oct; 67(10):5124-32. PubMed ID: 10496886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain.
    Hussack G; Arbabi-Ghahroudi M; van Faassen H; Songer JG; Ng KK; MacKenzie R; Tanha J
    J Biol Chem; 2011 Mar; 286(11):8961-76. PubMed ID: 21216961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin.
    Boyd B; Richardson S; Gariepy J
    Infect Immun; 1991 Mar; 59(3):750-7. PubMed ID: 1705242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography.
    Orth P; Xiao L; Hernandez LD; Reichert P; Sheth PR; Beaumont M; Yang X; Murgolo N; Ermakov G; DiNunzio E; Racine F; Karczewski J; Secore S; Ingram RN; Mayhood T; Strickland C; Therien AG
    J Biol Chem; 2014 Jun; 289(26):18008-21. PubMed ID: 24821719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal Antibodies to the C Terminus of Toxin A Prevent Colonization of Clostridium difficile.
    Hong HA; Hitri K; Hosseini S; Kotowicz N; Bryan D; Mawas F; Wilkinson AJ; van Broekhoven A; Kearsey J; Cutting SM
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28167669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease.
    Johnson S; Sypura WD; Gerding DN; Ewing SL; Janoff EN
    Infect Immun; 1995 Aug; 63(8):3166-73. PubMed ID: 7622244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of a fundamental repeating unit in streptococcal glucosyltransferase glucan-binding regions and related sequences.
    Giffard PM; Jacques NA
    J Dent Res; 1994 Jun; 73(6):1133-41. PubMed ID: 8046101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Streptococcus mutans glucosyltransferase activity by antiserum to a subsequence peptide.
    Dertzbaugh MT; Macrina FL
    Infect Immun; 1990 Jun; 58(6):1509-13. PubMed ID: 2140339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile.
    Martinez RD; Wilkins TD
    J Med Microbiol; 1992 Jan; 36(1):30-6. PubMed ID: 1370542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A.
    Gardiner DF; Rosenberg T; Zaharatos J; Franco D; Ho DD
    Vaccine; 2009 Jun; 27(27):3598-604. PubMed ID: 19464540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
    Torres JF; Monath TP
    J Med Microbiol; 1996 Jun; 44(6):464-74. PubMed ID: 8636964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.
    Corthier G; Muller MC; Wilkins TD; Lyerly D; L'Haridon R
    Infect Immun; 1991 Mar; 59(3):1192-5. PubMed ID: 1900059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New method to generate enzymatically deficient Clostridium difficile toxin B as an antigen for immunization.
    Genth H; Selzer J; Busch C; Dumbach J; Hofmann F; Aktories K; Just I
    Infect Immun; 2000 Mar; 68(3):1094-101. PubMed ID: 10678912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monospecific antibodies for detection of Clostridium difficile enterotoxin.
    Rautenberg P; Stender F; Ullmann U
    Eur J Clin Microbiol; 1987 Feb; 6(1):62-4. PubMed ID: 3552665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.